P. Kari

发表

Metabolites of caspofungin acetate, a potent antifungal agent, in human plasma and urine.

T. Baillie, X. Xu, D. Dean, 2000, Drug metabolism and disposition: the biological fate of chemicals.

Biotransformation of lovastatin. II. In vitro metabolism by rat and mouse liver microsomes and involvement of cytochrome P-450 in dehydrogenation of lovastatin.

D. E. Duggan, S. Prakash, P. Kari, 1990, Drug metabolism and disposition: the biological fate of chemicals.

HMG-CoA reductase inhibitor-induced myopathy in the rat: cyclosporine A interaction and mechanism studies.

S. Grossman, P. F. Smith, J. MacDonald, 1991, The Journal of pharmacology and experimental therapeutics.

Regioselectivity and stereoselectivity in the metabolism of HMG-CoA reductase inhibitors.

S. Pitzenberger, P. Kari, K. Vyas, 1990, Biochemical and biophysical research communications.

In vitro and in vivo biotransformation of simvastatin, an inhibitor of HMG CoA reductase.

B. Arison, S. Pitzenberger, G. Stokker, 1990, Drug metabolism and disposition: the biological fate of chemicals.

Biotransformation of lovastatin. V. Species differences in in vivo metabolite profiles of mouse, rat, dog, and human.

D. Hunninghake, E. Ulm, D. E. Duggan, 1993, Drug metabolism and disposition: the biological fate of chemicals.

Biotransformation of lovastatin. IV. Identification of cytochrome P450 3A proteins as the major enzymes responsible for the oxidative metabolism of lovastatin in rat and human liver microsomes.

A. Y. Lu, F. Guengerich, P. Thomas, 1991, Archives of biochemistry and biophysics.

Biotransformation of lovastatin. I. Structure elucidation of in vitro and in vivo metabolites in the rat and mouse.

W. F. Hoffman, B. Arison, E. Ulm, 1990, Drug metabolism and disposition: the biological fate of chemicals.

Metabolism of A dopamine D(4)-selective antagonist in rat, monkey, and humans: formation of A novel mercapturic acid adduct.

T. Baillie, G. Doss, M. Davis, 2000, Drug metabolism and disposition: the biological fate of chemicals.

Population pharmacokinetic modeling for enterohepatic recirculation in Rhesus monkey.

A. D. Rodrigues, Wei Yang Lu, P. Lu, 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

IV. Identification of Cytochrome P450 3A Proteins as the Major Enzymes Responsible for the Oxidative Metabolism of Lovastatin in Rat and Human Liver Microsomes

A. Y. Lu, F. Guengerich, P. Thomas, 1991 .

Influence of beta-adrenoceptor antagonists on the pharmacokinetics of rizatriptan, a 5-HT1B/1D agonist: differential effects of propranolol, nadolol and metoprolol.

L. Tomasko, T. Olah, M. Goldberg, 2001, British journal of clinical pharmacology.

Biotransformation of lovastatin--III. Effect of cimetidine and famotidine on in vitro metabolism of lovastatin by rat and human liver microsomes.

A. Y. Lu, P. Kari, R. Wang, 1990, Biochemical pharmacology.